Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ramucirumab
Related studies linked through entity extraction aliases.
A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ramucirumab in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2